A strategy for distinguishing optimal cancer subtypes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Cancer

• Publication date

  2011-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.25714PMID 20949563PMCID PMC3043163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• Tumor marker phenotype concordance in second primary breast cancer, California, 1999–2004

  2010cited by this paper
• The molecular pathology of cancer

  2010cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• Evaluating Cancer Epidemiologic Risk Factors Using Multiple Primary Malignancies

  2010cited by this paper
• Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

  2009cited by this paper
• Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

  2009cited by this paper
• Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers

  2009cited by this paper
• Challenges in studying the etiology of breast cancer subtypes

  2009cited by this paper
• Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis

  2009cited by this paper
• Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

  2008cited by this paper
• Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

  2008cited by this paper
• Searching for susceptibility alleles: Emphasis on bilateral breast cancer

  2007cited by this paper
• Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer

  2007cited by this paper
• Bilateral breast cancer: differential diagnosis using histological and biological parameters.

  2007cited by this paper
• Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study

  2007cited by this paper
• Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

  2006cited by this paper
• Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies

  2006cited by this paper
• A Comparison of Bilateral Breast Cancers in BRCA Carriers

  2005cited by this paper
• Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

  2005cited by this paper
• Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours.

  2005cited by this paper
• Concordance of the Hormone Receptors and Correlation of HER‐2/neu Overexpression of the Metachronous Cancers of Contralateral Breasts

  2005cited by this paper
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005cited by this paper
• The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas

  2005cited by this paper
• Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

  2004cited by this paper
• Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

  2004cited by this paper
• Phenotypic similarities in bilateral breast cancer

  2004cited by this paper
• The molecular biology of mucosal field cancerization of the head and neck.

  2003cited by this paper
• Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

  2002cited by this paper
• Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifen.

  2002cited by this paper
• Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas

  2002cited by this paper
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

  2002cited by this paper
• On the use of familial aggregation in population-based case probands for calculating penetrance.

  2002cited by this paper
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

  2002cited by this paper
• High constant incidence in twins and other relatives of women with breast cancer

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Molecular pathology of cancer

  1997cited by this paper
• A note on the estimation of relative risks of rare genetic susceptibility markers.

  1997cited by this paper
• Statistical analysis of molecular epidemiology studies employing case-series.

  1994cited by this paper
• Estrogen receptors in bilateral breast cancer

  1988cited by this paper

• Efficiency for evaluation of disease etiologic heterogeneity in case-case and case-control studies

  2025cites this paper
• Improve the model of disease subtype heterogeneity by leveraging external summary data

  2023cites this paper
• Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity

  2022cites this paper
• Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study

  2019cites this paper
• Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?

  2018cites this paper
• Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma

  2017influential citation
• Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries

  2017cites this paper
• Integration of molecular pathology, epidemiology and social science for global precision medicine

  2016cites this paper
• Statistical methods for studying disease subtype heterogeneity

  2016cites this paper
• The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma

  2016cites this paper
• THE THIRD INTERNATIONAL MOLECULAR PATHOLOGICAL EPIDEMIOLOGY (MPE) MEETING

  2016cites this paper
• Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression

  2015cites this paper
• Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer

  2015cites this paper
• Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology

  2014cites this paper
• Re: "Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors".

  2014cites this paper
• RE: "NULL ASSOCIATION BETWEEN HISTOLOGY OF FIRST AND SECOND PRIMARY MALIGNANCIES IN MEN WITH BILATERAL TESTICULAR GERM CELL TUMORS"

  2014cites this paper
• Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors.

  2013cites this paper
• Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

  2013cites this paper
• A conceptual and methodological framework for investigating etiologic heterogeneity

  2013cites this paper
• How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

  2012cites this paper
• Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

  2012cites this paper
• Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

  2012cites this paper
• Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms

  2012cites this paper
• Age-Associated Gene Expression in Normal Breast Tissue Mirrors Qualitative Age-at-Incidence Patterns for Breast Cancer

  2012cites this paper